SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-20-011475
Filing Date
2020-05-08
Accepted
2020-05-08 17:03:55
Documents
61
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2019_actiniumpharma.htm 10-K 1061418
2 CONSENT OF MARCUM LLP. f10k2019ex23-1_actinium.htm EX-23.1 2408
3 CERTIFICATION f10k2019ex31-1_actinium.htm EX-31.1 12650
4 CERTIFICATION f10k2019ex31-2_actinium.htm EX-31.2 12711
5 CERTIFICATION f10k2019ex32-1_actinium.htm EX-32.1 3744
6 CERTIFICATION f10k2019ex32-2_actinium.htm EX-32.2 3682
  Complete submission text file 0001213900-20-011475.txt   3940969

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE atnm-20191231.xml EX-101.INS 518713
8 XBRL SCHEMA FILE atnm-20191231.xsd EX-101.SCH 50696
9 XBRL CALCULATION FILE atnm-20191231_cal.xml EX-101.CAL 38967
10 XBRL DEFINITION FILE atnm-20191231_def.xml EX-101.DEF 162012
11 XBRL LABEL FILE atnm-20191231_lab.xml EX-101.LAB 356847
12 XBRL PRESENTATION FILE atnm-20191231_pre.xml EX-101.PRE 257162
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36374 | Film No.: 20861553
SIC: 2834 Pharmaceutical Preparations